[EN] HEPATITIS C INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE L'HÉPATITE C
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2012019299A1
公开(公告)日:2012-02-16
Compounds of Formula (I) (Formula (I)) wherein R1, R2, R3, R4 and n are defined herein, are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.